The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The numbers in these Tenders are incredible, roll on CE Marking!!!
Nice to hear Gestapo Giles interviewing Alistair again, cheers McGurk
"The partnership also provides the company with additional manufacturing capacity through Mologic’s and its partners including Global Access Diagnostics (GAD). This adds to the scaled-up capacity being built with BBI and Abingdon Health (ABDX:AIM)."
https://www.sharesmagazine.co.uk/news/shares/avacta-signs-deal-to-accelerate-market-access-for-rapid-covid-19-test
Yes definitely AgentB, can you imagine if your all set for your holiday flight having gotten over a recent bout of Covid weeks ago, you arrive at the airport and have a PCR test which says you cant fly, even though your not shedding any virus!
A quick accurate Lateral Flow Test that checks are you shedding Virus now is crucial rather than a test that keeps detecting old virus RNA in your body
Ndn71,
You're right, the most important aspect of what Avacta do is the technology and the fact that world class companies are choosing to work with them - that's the key for me, the outside validation of their product, it's MASSIVE and should give all genuine holders real comfort. Every licensing deal after such thorough evaluation, that can take a year or two is another huge endorsement for Avacta. Delays are annoying and trying, but when you listen to or read what Dominic Cummings has just said, and the fact we are in a Pandemic then delays are understandable when you are bringing NEW tech to market.
I think a shake up is definitely needed and is coming (or should that be cumming :) - The defence review yesterday was VERY revealing, and will I'm sure bring more money and Kudos the way of companies like Avacta, because we are becoming more essential and more important and the fact we are now incorporated within the Defense budget is really interesting!
Also the fact that we can bring in people of the calibre of Neil Bell is a massive endorsement
The future here is very bright indeed!!
Someone posted this link earlier and tried to insinuate that Avacta's BAMS test had failed, when it was clearly not the case. In fact a look through this list is REALLY encouraging, basically there is a big race with lots of horses, and looking down the list many are failing and falling at the hurdles. BUT Avacta are still in the race with ALL 4 of their TESTS. Yes we might have been slower than we all would have liked, but we haven't yet fallen at any of the hurdles, in fact we are in the final furlong with others slowing down and falling around us!!!
WE HAVE FAR LESS COMPETITION NOW THAN WHEN WE STARTED THE RACE
https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/products-in-the-pipeline-tvg-validation-concluded-or-paused
"AVA6000 is around a year late"
Errrrr yeah, I think the biggest global pandemic for 100 years might have some small thing to do with that, and the massive backlog of Cancer treatments!!!!! Cancer Treatments have fallen off a cliff because of Covid, many many people need treatment and are probably going to die because of the Pandemic.
At the time of the last great Pandemic in 1918, Science hadn't yet worked out what caused it, we still hadn't discovered what a Virus was!! Now we are at the cusp of the next great change in Medical treatments in the Century of Biotech, with great companies like Avacta helping to push the boundaries in ground breaking collaborations with some of the worlds best companies.
The money Avacta will be paid when Moderna and AffiXell start secreting Affimers into the body, and the Cancer Therapeutics start rolling out, we will look back and laugh about the Covid testing malarky - it's just the icing on a large and growing cake.
Look at Silence Therapeutics, they have almost no income but are priced for future blockbuster status, we are starting to be but we will have a revenue stream coming in from Covid Testing sooner rather than later. We also have the growing Diagnostics and Cancer Therapeutics licensing deals of which we are expecting at least another 8 or 9 evaluations to come through soon!
I don't see any of the other Covid 'competitors' signing licensing deals like we are with some of the global giants, so much to look forward to
Onward Avacta
A dummy sell of 44,000 was available if i was crazy enough to want to, people are eager to gobble up available shares alright
People need to stop worrying about the short term fluctuations in share price and sentiment, putting it in a nutshell Avacta state it clearly on the front page of their website:
"Signifcant Long Term Value, Growing a Pipeline of Drug Candidates and Powerful Diagnostic Products"
Sounds like Moderna have a few targets for Affimers in mind
"Moderna have Affimer molecules of interest" - Alistair said
Yes he is giving more exposure and highlighting Avacta BUT he needs to refine and control his interview technique more. It is the interviewee who should be expressing and communicating what they need to and be allowed the time and space without interruption
"Who is Mr Market?
One of Roger Hargreaves characters?"
Haha fantastic, we definitely need a Mr Market, so much material there, bring back Mister Men now, made my day, along with the growing realisation of what a great future Avacta and my pension pot has :)
"Time is on your side when you own shares of superior companies" - Peter Lynch
WOW! the whole Affimer platform is worth Billions clearly now, there's so much Alistair can't say. But safe to say, Avacta's valuation will be massive if all these different cutting edge Biotech's like Moderna and Daewoong are going to be getting their RNA and Stem Cells to produce Affimers in the body!!! Incredible stuff, crazy valuations coming down the line for Avacta!
He's clearly been on the Sugar again this morning!
FFS Skinner shut the F**K up and let the master speak!!!!!!!!!
Frank is beginning to think he's the star
Fantastic news for Deepverge and further validation and another revenue stream for Avacta
Sorry Kaeren
Really good article, I Still haven't begun to explore the spin off links from the article which look really interesting too
Yeah Biotech is going to undergo the same kind of rapid change that electronics saw in the last 50 years. Interesting article I came across the other day covering what Avacta are doing in the Cancer Therapeutics:
https://www.cancer.gov/news-events/cancer-currents-blog/2020/radiopharmaceuticals-cancer-radiation-therapy